Diagnóstico, tratamiento y seguimiento de la eyaculación precoz: recomendaciones de experto

Abstract

ObjectivesTo develop recommendations on the diagnosis, treatment and monitoring of premature ejaculation (PE). Material and methodA multidisciplinary group of experts created clinical questions. Based on a non-exhaustive systematic review and their clinical experience, recommendations were developed and validated in a Delphi round and, after that, in a meeting. ResultsInterviews are essential for the diagnosis of PE, which has to be complemented with a physical examination and the use of specific questionnaires. Psychological treatment of PE with sex therapy and behavioral techniques is effective, and it is more effective when combined with drug treatment. The use of anesthetic agents or surgical interventions is not recommended. Selective serotonin reuptake inhibitors (SSRIs) are effective and safe, being dapoxetine the only drug with specific indication for PE. Inhibitors of phosphodiesterase type5 have not enough evidence to support their use. There are no standardized monitoring strategies for this disease, although tools such as scales, questionnaires or self-esteem intravaginal latency time for response assessment can be used, in addition to specific follow-up visits if the patient is taking SSRIs. ConclusionsThis consensus proposes several recommendations regarding the management of PE according to evidence and clinical experience and aims at being a useful clinical instrument for the management of these patients.